Building a Future-Ready Pharma Ecosystem with AI and Sustainable Development Goals (SPER-2026)

The 15th Annual International Conference & Exhibition of the Society of Pharmaceutical Education and Research (SPER 2026) is a premier global event dedicated to advancing pharmaceutical sciences, healthcare innovation, and multidisciplinary research. Organized in proud association with the School of Pharmaceutical Sciences (SPS), Lovely Professional University, the conference will bring together distinguished scientists, academicians, industry leaders, healthcare professionals, entrepreneurs, and research scholars from across India and abroad.

SPER 2026 aims to provide a dynamic platform to showcase cutting-edge research, emerging technologies, and translational advancements that shape the future of healthcare and drug development. The event will feature keynote lectures by eminent personalities, plenary and technical sessions, panel discussions, oral and poster presentations, workshops, and an exclusive industrial exhibition highlighting novel technologies, instrumentation, and pharmaceutical products.

The conference will particularly emphasize contemporary challenges and innovations in drug formulation, regulatory affairs, pharmacovigilance, biotechnology, clinical research, phytopharmaceuticals, and patient-centric healthcare solutions. It will also serve as a networking hub, fostering collaborations between academia, industry, and regulatory bodies.

Lovely Professional University, known for its world-class infrastructure and research ecosystem, will host participants in an environment that promotes learning, innovation, and global engagement. SPER 2026 also includes cultural events, recognition awards, and opportunities for young researchers to interact with leading experts.

By fostering scientific exchange and professional growth, the 15th Annual International Conference & Exhibition (SPER 2026) promises to contribute significantly to the advancement of pharmaceutical sciences and the healthcare sector at large.

• To explore the integration of Artificial Intelligence in pharmaceutical education, research, and industry for enhanced innovation and productivity.
• To promote sustainable practices in pharma aligned with the United Nations SDGs, with a focus on responsible consumption, green technologies, and environmental protection.
• To discuss emerging AI-driven solutions for drug discovery, patient-centric care, quality assurance, and regulatory compliance.